参考文献/References:
[1] 张海澄,郭继鸿.冠心病流行病学与一级预防.中国实用内科杂志,2002, 22(8):449-451.
[2] 吴锡桂.我国人群冠心病流行现况与趋势.中国慢性病预防与控制,2003, 11(4):190-191.
[3] 刘小清.冠心病流行病学研究进展及疾病负担.中华心血管病杂志,2008, 36(6):573-576.
[4] Taimeh Z, Loughran J, Birks EJ, et al. Vascular endothelial growth factor in heart failure. Nat Rev Cardiol, 2013, 10(9):519-530.
[5] Woolard J, Bevan HS, Harper SJ, et al. Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation, 2009,16(7):572-592.
[6] Zhao T, Zhao W, Chen Y, et al. Vascular endothelial growth factor (VEGF)-A:role on cardiac angiogenesis following myocardial infarction. Microvasc Res, 2010, 80(2):188-194.
[7] Nam JO, Son HN, Jun E, et al. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin. Mol Cancer Res, 2012, 10(8):1010-1020.
[8] Ruixing Y, Jiaquan L, Jie C, et al. Intravenous administration of vascular endothelial growth factor improves cardiac performance and inhibits cardiomyocyte apoptosis. Growth Factors, 2006, 24(3):209-217.
[9] Hao X, M?nsson-Broberg A, Grinnemo KH, et al. Myocardial angiogenesis after plasmid or adenoviral VEGF-A165 gene transfer in rat myocardial infarction model. Cardiovasc Res, 2007, 73(3):481487.
[10] Yan D, Wang X, Li D, et al. Macrophages overexpressing VEGF target to infarcted myocardium and improve neovascularization and cardiac function. Int J Cardiol, 2013, 164(3):334-338.
[11] Morishita R, Aoki M, Yo Y, et al. Hepatocyte growth factor as cardiovascular hormone:role of HGF in the pathogenesis of cardiovascular disease. Endocr J, 2002,49(3):273-284.
[12] Salimath AS, Phelps EA, Boopathy AV, et al. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats[J/OL]. PLoS One, 2012, 7(11):e50980[2012-12-24]. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjoumal.pone.0050980.
[13] Paradiso B, Zucchini S, Simonato M. Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements[J/OL]. Front Cell Neurosci, 2013, 7:1-9[2012-12-24]. http://www.readcube.com/articles/10.3389/fncel.2013.00152.
[14] Gao MH, Lai NC, McKiman MD, et al. Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4:report of preclinical data. Hum Gene Ther, 2004,15(6):574-587.
[15] Suzuki G, Lee TC, Fallavollita JA, et al. Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle. Circ Res, 2005, 96(7):767-775.
[16] McCarter SD, Mei SH, Lai PF, et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med, 2007, 175(10):1014-1026.
[17] Mei SH, McCarter SD, Deng Y, et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin l[J/OL]. PLoS Med, 2007, 4(9):e269[2012-12-24]. http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjoumal.pmed.0040269.
[18] 朱成楚,陈仕林,刘玉清,等.rAAV2VEGF165与rAAV2AN-1联合转染促猪缺血心肌血管生成的研究.浙江大学学报:医学版,2010, 39(6):610-617.
[19] 黄盛东,刘晓红,白辰光,等.重组腺病毒介导的血管生成素改善缺血性心脏病的实验研究.中华老年心脑血管病杂志,2007, 9(3):192-195.
[20] 王潇,陈茜,周青,等.SonoVue微泡介导转染Ang-1基因治疗急性心肌梗死.中国医学影像技术,2009,25(11):1969-1971.
[21] Tuo QH, Xiong GZ, Zeng H, et al. Angiopoietin-1 protects myocardial endothelial cell function blunted by angiopoietin-2 and high glucose condition. Acta pharmacol Sin, 2011, 32(1):45-51.
[22] Tao Z, Chen B, Tan X, et al. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proo Nall Acad Sci U S A, 2011,108(5):2064-2069.
[23] Yuan G, Peng YJ, Reddy VD, et eil. Mutual antagonism between hypoxia-inducible factors la and 2a regulates oxygen sensing and cardio-respiratory homeostasis. Proc Natl Acad Sci USA. 2013, 110(19):E1788-1796.
[24] D’Angelo G, Duplan E, Boyer N, et al. Hypoxia up-regulates prolyl hydroxylase activity:a feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem, 2003, 278(40):38183-38187.
[25] Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995, 92(12):5510-5514.
[26] Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood, 2005,105(2):659-669.
[27] Semenza GL Hypoxia-inducible factor 1(HIF-1) pathway[J/OL]. Sci STKE, 2007,2007(407):cm8[2012-12-24]. http://stke.sciencemag.org/cgi/content/abstract/2007/407/cm8.
[28] Brahimi-Hom C, Pouysségur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer, 2006, 93(8):E73-80.
[29] Hinkel R, Lebherz C, Fydanaki M, et al. Angiogenetic potential of Ad2/Hif-lα/VP16 after regional application in a preclinical pig model of chronic ischemia. Curr Vase Pharmacol. 2013, 11(1):29-37.
[30] 牛铁生.缺氧诱导因子1对大鼠心肌梗死及再灌注损伤的保护作用研究.沈阳:中国医科大学,2007.
[31] Huang Y, Hickey RP, Yeh JL, et al. Cardiac myocyte-specific HIF-α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J. 2004, 18(10):1138-1140.
[32] Vale PR, Losordo DW, Milliken CE, et al. Randomized, singleblind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromecheinical mapping in patients with chronic myocardial ischemia. Circulation, 2001, 103(17):2138-2143.
[33] Shyu KG, Wang MT, Wang BW, et al. Intramyocardial injection of naked DNA encoding HIF-lα/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res, 2002, 54(3):576-583.
[34] Dong F, Khalil M, Kiedrowski M, et al. Critical role for leukocyte hypoxia inducible factor-lot expression in post-myocardial infarction left ventricular remodeling. Circ Res, 2010, 106(3):601-610.
相似文献/References:
[1]樊孝廉,舒毅,曾春平,等.99Tcm-MIBI门控心肌灌注显像在2型糖尿病无症状心肌缺血患者中的价值[J].国际放射医学核医学杂志,2016,40(3):171.[doi:10.3760/cma.j.issn.1673-4114.2016.03.002]
Fan Xiaolian,Shu Yi,Zeng Chunping,et al.Significance of 99Tcm-MIBI gated myocardial perfusion imaging in patients with type 2 diabetes but without myocardial ischemia symptoms[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):171.[doi:10.3760/cma.j.issn.1673-4114.2016.03.002]
[2]蔡琳婷,陈文新.心肌细胞葡萄糖转运蛋白4的转运调控及与心肌活力关系的研究进展[J].国际放射医学核医学杂志,2013,37(1):47.[doi:10.3760/cma.j.issn.1673-4114.2013.01.013]
CAI Lin-ting,CHEN Wen-xin.Recent advances on the regulation of glucose transporter 4 transport and its relationship with myocardial viability in cardiomyocytes[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):47.[doi:10.3760/cma.j.issn.1673-4114.2013.01.013]
[3]苏云龙,王雪梅.123I-β-甲基-p-碘苯基十五烷酸心肌显像研究进展[J].国际放射医学核医学杂志,2012,36(1):16.[doi:10.3760/cma.j.issn.1673-4114.2012.01.004]
SU Yun-long,WANG Xue-mei.Advances in β-methyl-p-iodophenyl pentadecanoic acid myocardial imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):16.[doi:10.3760/cma.j.issn.1673-4114.2012.01.004]
[4]韩萍萍,颜珏.SPECT心肌灌注显像在糖尿病无症状性心肌缺血中的临床价值[J].国际放射医学核医学杂志,2013,37(6):385.[doi:10.3760/cma.j.issn.1673-4114.2013.06.015]
HAN Ping-ping,YAN Jue.Clinical value of SPECT myocardial perfusion imaging for diabetic patients with silent myocardial ischemia[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):385.[doi:10.3760/cma.j.issn.1673-4114.2013.06.015]
[5]张国鹏,张永学.心肌缺血性疾病基因治疗及分子影像监测进展[J].国际放射医学核医学杂志,2008,32(5):257.
ZHANG Guo-peng,ZHANG Yong-xue.Advances in gene therapy of myocardial ischemia and the monitoring with molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):257.
[6]武志芳.SPECT心肌灌注显像对糖尿病心肌缺血损伤的研究[J].国际放射医学核医学杂志,2004,28(3):105.
WU Zhi-fang.The study of SPECT myocardial perfusion imaging in detecting myocardial ischemia of diabetic patient[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(6):105.
[7]吕宇航,孙凯.双源CT双能量心肌血池成像的应用及研究进展[J].国际放射医学核医学杂志,2018,(2):173.[doi:10.3760/cma.j.issn.1673-4114.2018.02.013]
Lyu Yuhang,Sun Kai.Application and research progress of dual-energy myocardial blood pool imaging by dual-source computed tomography[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):173.[doi:10.3760/cma.j.issn.1673-4114.2018.02.013]